Price loading...

The 2023-2028 World Outlook for Granulocyte Colony Stimulating Factor (G-CSF) Cancer Supportive Care

Price data last checked 109 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

No Price Data Available

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
10 May 2022
Listed Since
06 May 2022

Similar Products You Might Like

The 2023-2028 Outlook for Cancer Supportive Care in the United States
96% match

The 2023-2028 Outlook for Cancer Supportive Care in the United States

£520.00 24 Jan 2026
The 2023-2028 World Outlook for Genomics in Cancer Care
96% match

The 2023-2028 World Outlook for Genomics in Cancer Care

£795.00 25 Jan 2026
The 2023-2028 Outlook for Cancer Supportive Care Drugs in the United States
96% match

The 2023-2028 Outlook for Cancer Supportive Care Drugs in the United States

£520.00 22 Jan 2026
The 2023-2028 Outlook for Cancer Supportive Care Drugs in India
96% match

The 2023-2028 Outlook for Cancer Supportive Care Drugs in India

£515.00 22 Jan 2026
The 2023-2028 World Outlook for Basal Cell Carcinoma Treatments
96% match

The 2023-2028 World Outlook for Basal Cell Carcinoma Treatments

£795.00 06 Jan 2026
The 2023-2028 World Outlook for Carcinoembryonic Antigen
96% match

The 2023-2028 World Outlook for Carcinoembryonic Antigen

£795.00 12 Jan 2026
The 2023-2028 World Outlook for Tumor-Specific Antigen
96% match

The 2023-2028 World Outlook for Tumor-Specific Antigen

£795.00 08 Feb 2026
The 2023-2028 World Outlook for Colorectal Cancer Drugs
96% match

The 2023-2028 World Outlook for Colorectal Cancer Drugs

£795.00 12 Feb 2026
The 2023-2028 Outlook for Gynecologic Oncology in the United States
95% match

The 2023-2028 Outlook for Gynecologic Oncology in the United States

£520.00 01 Feb 2026
The 2023-2028 World Outlook for Gamma Knife Radiosurgery
95% match

The 2023-2028 World Outlook for Gamma Knife Radiosurgery

£795.00 11 Jan 2026
The 2023-2028 World Outlook for Non-Hodgkin Lymphoma Treatments
95% match

The 2023-2028 World Outlook for Non-Hodgkin Lymphoma Treatments

£795.00 13 Dec 2025
The 2023-2028 World Outlook for Cervical Cancer Treatments
95% match

The 2023-2028 World Outlook for Cervical Cancer Treatments

£795.00 30 Jan 2026
The 2023-2028 World Outlook for Chemotherapy and Antibody Combination Antibody Therapies
95% match

The 2023-2028 World Outlook for Chemotherapy and Antibody Combination Antibody Therapies

£795.00 25 Feb 2026
The 2023-2028 World Outlook for Chemotherapy for Endometrial Cancers
95% match

The 2023-2028 World Outlook for Chemotherapy for Endometrial Cancers

£795.00 02 Apr 2026
The 2023-2028 World Outlook for Critical and Chronic Care Products
95% match

The 2023-2028 World Outlook for Critical and Chronic Care Products

£795.00 10 Mar 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in the United States
95% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in the United States

£520.00 24 Jan 2026
The 2023-2028 Outlook for Cancer Screenings in the United States
95% match

The 2023-2028 Outlook for Cancer Screenings in the United States

£520.00 15 Jan 2026
The 2023-2028 Outlook for Basal Cell Carcinoma Treatments in the United States
95% match

The 2023-2028 Outlook for Basal Cell Carcinoma Treatments in the United States

£520.00 12 Jan 2026
The 2023-2028 World Outlook for Uterine Cancer Treatments and Diagnostics
95% match

The 2023-2028 World Outlook for Uterine Cancer Treatments and Diagnostics

£795.00 26 Jan 2026
The 2023-2028 World Outlook for Cell Culture in Healthcare
95% match

The 2023-2028 World Outlook for Cell Culture in Healthcare

£795.00 08 Jan 2026
The 2023-2028 World Outlook for Guillain-Barre Syndrome Therapeutics
95% match

The 2023-2028 World Outlook for Guillain-Barre Syndrome Therapeutics

£795.00 11 Feb 2026
The 2023-2028 Outlook for Basal Cell Carcinoma Surgeries in the United States
95% match

The 2023-2028 Outlook for Basal Cell Carcinoma Surgeries in the United States

£520.00 11 Jan 2026
The 2023-2028 World Outlook for Embolization in Interventional Oncology
95% match

The 2023-2028 World Outlook for Embolization in Interventional Oncology

£795.00 28 Mar 2026
The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in the United States
95% match

The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in the United States

£520.00 12 Jan 2026